N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:3121284-72-5 also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0144116 |
| CAS No | NA |
| Mol.F. | C9H11ClN2O7S2 |
| Mol.Wt. | 358.76 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144117 |
| CAS No | NA |
| Mol.F. | C7H7ClN2O4S2 |
| Mol.Wt. | 282.71 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144118 |
| CAS No | NA |
| Mol.F. | C9H9ClN2O7S2 |
| Mol.Wt. | 356.75 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144119 |
| CAS No | NA |
| Mol.F. | C9H10N2O7S2 |
| Mol.Wt. | 322.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144120 |
| CAS No | NA |
| Mol.F. | C6H5ClN2O5S2 |
| Mol.Wt. | 284.69 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144121 |
| CAS No | NA |
| Mol.F. | C6H5ClN2O5S2 |
| Mol.Wt. | 284.69 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144122 |
| CAS No | NA |
| Mol.F. | C16H26N4O4 |
| Mol.Wt. | 338.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144123 |
| CAS No | NA |
| Mol.F. | C16H12ClFN4O4 |
| Mol.Wt. | 378.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144124 |
| CAS No | NA |
| Mol.F. | C5H7N3O |
| Mol.Wt. | 125.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144125 |
| CAS No | NA |
| Mol.F. | C9H17N3O2 |
| Mol.Wt. | 199.30 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144126 |
| CAS No | NA |
| Mol.F. | C5H13N3O |
| Mol.Wt. | 131.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144127 |
| CAS No | NA |
| Mol.F. | C29H29F6N5O2 |
| Mol.Wt. | 593.6 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0144128 |
| CAS No | NA |
| Mol.F. | C23H23FN6O3S2 |
| Mol.Wt. | 514.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144129 |
| CAS No | NA |
| Mol.F. | C23H23FN6O5S2 |
| Mol.Wt. | 546.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144130 |
| CAS No | NA |
| Mol.F. | C22H26FN3O5 |
| Mol.Wt. | 431.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |